×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
THTX – theratechnologies inc. - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
THTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
07:25 am
thtx
TSX futures flat as markets await clarity on tariffs [Yahoo! Finance Canada]
High
Report
TSX futures flat as markets await clarity on tariffs [Yahoo! Finance Canada]
3/25
05:45 pm
thtx
Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy
High
Report
Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy
3/12
07:30 am
thtx
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI
Low
Report
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI
3/12
07:30 am
thtx
Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIV
Low
Report
Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIV
2/26
07:30 am
thtx
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
High
Report
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
2/19
06:32 am
thtx
Theratechnologies Inc. (NASDAQ: THTX) was upgraded by analysts at Research Capitl to a "strong-buy" rating.
Medium
Report
Theratechnologies Inc. (NASDAQ: THTX) was upgraded by analysts at Research Capitl to a "strong-buy" rating.
2/14
09:28 am
thtx
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update [Canadian Business Journal (Canada)]
Neutral
Report
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update [Canadian Business Journal (Canada)]
2/14
07:30 am
thtx
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
Medium
Report
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/26
12:52 pm
thtx
Form 6-K Theratechnologies Inc. For: Mar 26
Low
Report
Form 6-K Theratechnologies Inc. For: Mar 26
2/26
08:33 am
thtx
Form 20-F Theratechnologies Inc. For: Nov 30
High
Report
Form 20-F Theratechnologies Inc. For: Nov 30
2/26
08:30 am
thtx
Form 6-K Theratechnologies Inc. For: Feb 26
High
Report
Form 6-K Theratechnologies Inc. For: Feb 26
2/21
04:37 pm
thtx
Form 6-K Theratechnologies Inc. For: Feb 21
Low
Report
Form 6-K Theratechnologies Inc. For: Feb 21
2/14
03:21 pm
thtx
Form SCHEDULE 13G/A Theratechnologies Inc. Filed by: MORGAN STANLEY
Low
Report
Form SCHEDULE 13G/A Theratechnologies Inc. Filed by: MORGAN STANLEY
2/14
11:13 am
thtx
Form 6-K Theratechnologies Inc. For: Feb 14
Medium
Report
Form 6-K Theratechnologies Inc. For: Feb 14
2/14
10:52 am
thtx
Form 6-K Theratechnologies Inc. For: Feb 14
Medium
Report
Form 6-K Theratechnologies Inc. For: Feb 14
2/10
08:25 am
thtx
Form SCHEDULE 13G/A Theratechnologies Inc. Filed by: HIRSCHMAN ORIN
Low
Report
Form SCHEDULE 13G/A Theratechnologies Inc. Filed by: HIRSCHMAN ORIN
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/4
Theratechnologies Signs Agreements With Massachusetts General Hospital and Dr. Steven Grinspoon
19.1%
3/3 Theratechnologies Inc. (NASDAQ: THTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $95.50 price target on the stock. 17.7%
4/14 Theratechnologies Announces Financial Results for the First Quarter of 2020 11.8%
10/14 REMINDER - Tesamorelin Study Results on NAFLD Published in Lancet HIV 9.9%
4/16 Theratechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6.8%
10/21 Theratechnologies Provides Details About R&D Day Webcast 4.7%
3/11 Visceral Fat is a Predictor of Liver Fibrosis and Fibrosis Progression in People Living With HIV 3.8%
3/13 Form 6-K Theratechnologies Inc. For: Mar 13 3.4%
1/10 Theratechnologies Inc. (NASDAQ: THTX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 3.4%
12/19 Form 6-K Theratechnologies Inc. For: Dec 19 2.6%
3/3 Theratechnologies Inc. (NASDAQ: THTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $95.50 price target on the stock. 17.7%
4/14 Theratechnologies Announces Financial Results for the First Quarter of 2020 11.8%
10/14 REMINDER - Tesamorelin Study Results on NAFLD Published in Lancet HIV 9.9%
4/16 Theratechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6.8%
10/21 Theratechnologies Provides Details About R&D Day Webcast 4.7%
3/11 Visceral Fat is a Predictor of Liver Fibrosis and Fibrosis Progression in People Living With HIV 3.8%
3/13 Form 6-K Theratechnologies Inc. For: Mar 13 3.4%
1/10 Theratechnologies Inc. (NASDAQ: THTX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 3.4%
12/19 Form 6-K Theratechnologies Inc. For: Dec 19 2.6%
TOP News Decliners
11/15
Form F-10/A Theratechnologies Inc.
-12.3%
10/10 Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing -7.5%
4/15 Theratechnologies Inc. (THTX) Q1 2020 Earnings Call Transcript [The Motley Fool] -5.4%
12/2 Theratechnologies Inc. (NASDAQ: THTX) is now covered by analysts at Canaccord Genuity. They set a "buy" rating on the stock. -5.1%
11/22 Form EFFECT Theratechnologies Inc. -4.1%
3/31 Form 6-K Theratechnologies Inc. For: Mar 31 -3.6%
11/25 Theratechnologies Starts Commercialization of New EGRIFTA SV?? in the United States -2.6%
10/11 Form F-X Theratechnologies Inc. Filed by: Theratechnologies Inc. -2.0%
2/18 Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2019 -1.8%
3/10 Form 6-K Theratechnologies Inc. For: Mar 10 -1.7%
10/10 Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing -7.5%
4/15 Theratechnologies Inc. (THTX) Q1 2020 Earnings Call Transcript [The Motley Fool] -5.4%
12/2 Theratechnologies Inc. (NASDAQ: THTX) is now covered by analysts at Canaccord Genuity. They set a "buy" rating on the stock. -5.1%
11/22 Form EFFECT Theratechnologies Inc. -4.1%
3/31 Form 6-K Theratechnologies Inc. For: Mar 31 -3.6%
11/25 Theratechnologies Starts Commercialization of New EGRIFTA SV?? in the United States -2.6%
10/11 Form F-X Theratechnologies Inc. Filed by: Theratechnologies Inc. -2.0%
2/18 Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2019 -1.8%
3/10 Form 6-K Theratechnologies Inc. For: Mar 10 -1.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: